C.E Pharma: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
C.E Pharma
Largest movements
- Receivables within one year -€40,645
down €40,645 (-50.9%), from €79,778 to €39,133
of which Trade receivables: -€33,380
- Intangible fixed assets -€30,000
down €30,000 (-33.1%), from €90,575 to €60,575
- Current investments -€13,996
no longer reported in 2025 (was €13,996)
- Cash +€10,222
new in 2025: €10,222
mainly Receivables within one year (+€40,645) and Depreciation (+€40,232)
- Stocks and contracts +€7,105
up €7,105 (+18.4%), from €38,634 to €45,739
- Trade debts -€38,150
down €38,150 (-42.3%), from €90,286 to €52,136
- Debts after one year -€18,248
down €18,248 (-8.0%), from €228,374 to €210,125
- Profit (loss) carried forward -€17,197
down €17,197 (-44.1%), from -€38,970 to -€56,167
- Other debts -€9,407
down €9,407 (-42.2%), from €22,285 to €12,878
- Tax, wage and social debts +€8,585
up €8,585 (+143.8%), from €5,971 to €14,556
of which Remuneration and social security: +€7,388
- Gross operating margin +€24,208
up €24,208 (+29.6%), from €81,911 to €106,119
- Staff costs +€18,632
up €18,632 (+37.7%), from €49,481 to €68,113
- Other operating charges -€5,219
down €5,219 (-83.7%), from €6,236 to €1,017
- Financial charges +€2,272
up €2,272 (+22.7%), from €10,006 to €12,279
- Taxes +€1,942
new in 2025: €1,942
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €336,365 | €263,031 | -€73,333 | -21.8% |
| Fixed assets | 21/28 | €203,957 | €167,465 | -€36,492 | -17.9% |
| Intangible fixed assets | 21 | €90,575 | €60,575 | -€30,000 | -33.1% |
| Tangible fixed assets | 22/27 | €113,271 | €106,779 | -€6,492 | -5.7% |
| Land and buildings | 22 | €94,029 | €91,198 | -€2,831 | -3.0% |
| Furniture and vehicles | 24 | €19,242 | €15,581 | -€3,661 | -19.0% |
| Financial fixed assets | 28 | €111 | €111 | = | 0.0% |
| Current assets | 29/58 | €132,408 | €95,566 | -€36,842 | -27.8% |
| Stocks and contracts in progress | 3 | €38,634 | €45,739 | +€7,105 | +18.4% |
| Stocks | 30/36 | €38,634 | €45,739 | +€7,105 | +18.4% |
| Amounts receivable within one year | 40/41 | €79,778 | €39,133 | -€40,645 | -50.9% |
| Trade receivables | 40 | €72,335 | €38,955 | -€33,380 | -46.1% |
| Other amounts receivable | 41 | €7,444 | €178 | -€7,266 | -97.6% |
| Current investments | 50/53 | €13,996 | - | -€13,996 | |
| Cash at bank and in hand | 54/58 | - | €10,222 | +€10,222 | |
| Deferred charges and accrued income | 490/1 | - | €472 | +€472 | |
| Total equity and liabilities | 10/49 | €336,365 | €263,031 | -€73,333 | -21.8% |
| Equity | 10/15 | -€28,970 | -€46,167 | -€17,197 | -59.4% |
| Contributions | 10/11 | €10,000 | €10,000 | = | 0.0% |
| Profit (loss) carried forward | 14 | -€38,970 | -€56,167 | -€17,197 | -44.1% |
| Amounts payable | 17/49 | €365,335 | €309,199 | -€56,136 | -15.4% |
| Amounts payable after more than one year | 17 | €228,374 | €210,125 | -€18,248 | -8.0% |
| Financial debts | 170/4 | €228,374 | €210,125 | -€18,248 | -8.0% |
| Amounts payable within one year | 42/48 | €136,961 | €99,073 | -€37,888 | -27.7% |
| Current portion of amounts payable after more than one year | 42 | €18,419 | €19,503 | +€1,084 | +5.9% |
| Trade debts | 44 | €90,286 | €52,136 | -€38,150 | -42.3% |
| Suppliers | 440/4 | €90,286 | €52,136 | -€38,150 | -42.3% |
| Taxes, remuneration and social security | 45 | €5,971 | €14,556 | +€8,585 | +143.8% |
| Taxes | 450/3 | €2,593 | €3,790 | +€1,197 | +46.2% |
| Remuneration and social security | 454/9 | €3,378 | €10,766 | +€7,388 | +218.7% |
| Other amounts payable | 47/48 | €22,285 | €12,878 | -€9,407 | -42.2% |
| Remuneration, social security and pensions | 62 | €49,481 | €68,113 | +€18,632 | +37.7% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €38,902 | €40,232 | +€1,330 | +3.4% |
| Other operating charges | 640/8 | €6,236 | €1,017 | -€5,219 | -83.7% |
| Gross operating margin | 9900 | €81,911 | €106,119 | +€24,208 | +29.6% |
| Operating profit (loss) | 9901 | -€12,708 | -€3,243 | +€9,465 | +74.5% |
| Financial income | 75/76B | €23 | €268 | +€244 | +1043.1% |
| Recurring financial income | 75 | €23 | €268 | +€244 | +1043.1% |
| Financial charges | 65/66B | €10,006 | €12,279 | +€2,272 | +22.7% |
| Recurring financial charges | 65 | €10,006 | €12,279 | +€2,272 | +22.7% |
| Profit (loss) for the period before taxes | 9903 | -€22,691 | -€15,254 | +€7,437 | +32.8% |
| Income taxes | 67/77 | - | €1,942 | +€1,942 | |
| Profit (loss) for the period | 9904 | -€22,691 | -€17,197 | +€5,494 | +24.2% |
| Profit (loss) for the period to be appropriated | 9905 | -€22,691 | -€17,197 | +€5,494 | +24.2% |
Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 28 September 2026 via checked.be.